Friday, Dec. 4, 2015, 88 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $23.60 to $7,551,056.93.

Highlighted Stocks Traded by Insiders:

Loews (L) - FREE Research Report

Welters Anthony, who is Director at Loews, bought 3,000 shares at $38.31 on Dec. 4, 2015. Following this transaction, the Director owned 3,000 shares meaning that the stake was boosted by 100% with the 3,000-share transaction.

The shares most recently traded at $38.22, down $0.09, or 0.24% since the insider transaction. Historical insider transactions for Loews go as follows:

  • 4-Week # shares bought: 10,000
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 10,400
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 10,400

The average volume for Loews has been 1.7 million shares per day over the past 30 days. Loews has a market cap of $13.3 billion and is part of the financial sector and insurance industry. Shares are down 8.59% year-to-date as of the close of trading on Friday.

Loews Corporation, through its subsidiaries, operates as a commercial property and casualty insurance company primarily in the United States. The stock currently has a dividend yield of 0.67%. The company has a P/E ratio of 20.5. Currently, there is 1 analyst who rates Loews a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on L - FREE

TheStreet Quant Ratings rates Loews as a buy. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Loews Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

ADMA Biologics (ADMA) - FREE Research Report

Grossman Jerrold B, who is Director at ADMA Biologics, bought 6,000 shares at $9.16 on Dec. 4, 2015. Following this transaction, the Director owned 56,058 shares meaning that the stake was boosted by 11.99% with the 6,000-share transaction.

The shares most recently traded at $12.00, up $2.84, or 23.67% since the insider transaction. Historical insider transactions for ADMA Biologics go as follows:

  • 4-Week # shares bought: 1,361
  • 12-Week # shares bought: 1,361
  • 24-Week # shares bought: 1,361

The average volume for ADMA Biologics has been 7,200 shares per day over the past 30 days. ADMA Biologics has a market cap of $116.1 million and is part of the health care sector and drugs industry. Shares are up 60.26% year-to-date as of the close of trading on Friday.

ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases.

Exclusive Offer: Get the latest Stock Analysis on ADMA - FREE

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Computer (CSC) - FREE Research Report

Lawrie John M, who is President and CEO at Computer, sold 33,150 shares at $30.66 on Dec. 4, 2015. Following this transaction, the President and CEO owned 351,264 shares meaning that the stake was reduced by 8.62% with the 33,150-share transaction.

The shares most recently traded at $30.57, down $0.09, or 0.3% since the insider transaction. Historical insider transactions for Computer go as follows:

  • 4-Week # shares sold: 58,979
  • 12-Week # shares sold: 58,979
  • 24-Week # shares sold: 66,979

The average volume for Computer has been 3.0 million shares per day over the past 30 days. Computer has a market cap of $4.2 billion and is part of the technology sector and computer software & services industry. Shares are down 51.45% year-to-date as of the close of trading on Friday.

Computer Sciences Corporation provides information technology (IT) and professional services and solutions primarily in North America, Europe, Asia, and Australia. The company operates through Global Business Services, Global Infrastructure Services, and North American Public Sector segments. The stock currently has a dividend yield of 3.06%. The company has a P/E ratio of 120.3. Currently, there are 3 analysts who rate Computer a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CSC - FREE

TheStreet Quant Ratings rates Computer as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, growth in earnings per share and increase in net income. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Computer Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.